<DOC>
	<DOCNO>NCT00779805</DOCNO>
	<brief_summary>The objective study compare single dose oral bioavailability Pseudoephedrine hydrochloride 120 mg ER tablets Ranbaxy Sudafed 120 mg ER tablets Pfizer Consumer Health Care healthy , adult , human subject feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Pseudoephedrine HCl 120 mg ER Tablets Under Fed Conditions</brief_title>
	<detailed_description>This study open label , balance , randomize , two-treatment , two-period , two-sequence , single dose crossover bioavailability study plan 40 healthy , adult , human subject feed condition . A total forty ( 40 ) healthy , adult , human subject admit study allow dose first period . Out forty subject , thirty eight ( 38 ) subject complete period study .</detailed_description>
	<mesh_term>Pseudoephedrine</mesh_term>
	<mesh_term>Ephedrine</mesh_term>
	<criteria>Be age range 18 45 year Be neither weight weight his/ height per Life Insurance Corporation India height/ weight chart nonmedical case Have voluntarily give write informed consent participate study Be normal health determine medical history physical examination subject perform within 14 day prior commencement study If female : Of child bear potential practicing acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence ; Is postmenopausal least 1 year ; Is surgically sterile ( bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) History allergy Pseudoephedrine sympathomimetic drug History intake sympathomimetic drug glucocorticoid period 15 day prior day 1 study . Concurrent use monoamine oxidase inhibitor ( MAOI ) drug within 14 day prior day 1 study Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination Presence disease marker HIV 1 2 , hepatitis B C viruses syphilis infection Female volunteer demonstrate positive pregnancy test Female volunteer currently breastfeed Presence value significantly different normal reference range ( define appendix 5 ) and/ judge clinically significant serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose serum cholesterol Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/ HPF ) , glucose ( positive ) protein ( positive ) Clinically abnormal ECH chest Xray History serious gastrointestinal , hepatic , renal , pulmonary , neurological hematological disease glaucoma History cardiovascular disorder ( include hypertension ) , endocrine disorder , hyperthyroidism , diabetes mellitus , prostatic hypertrophy , palpitation , insomnia , tremor bronchial asthma History psychiatric illness may impair ability provide write informed consent Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period Use enzyme modify drug within 30 day prior day 1 study Participation clinical trail within 12 week precede day 1 study Subjects , completion study , would donate / lose 350 mL blood past 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence Pseudoephedrine hydrochloride 120 mg ER tablet</keyword>
</DOC>